Instruction for Authors
Bina Journal of Ophthalmology is an open access peer-reviewed quarterly journal published by the Eye Bank of I.R. Iran. This journal contains all clinical and technical aspects of ophthalmology and accepts original articles, review articles, case reports, surgical techniques and photo essays as well as letters to the editor and editorials. The mission of the journal is to promote the science and art of ophthalmology among ophthalmologists and allied professionals with the purpose of improving public health.
Manuscripts will be considered for publication with the clear understanding that their contents have not been previously published in Farsi (except for conventional abstracts presented at scientific meetings), and have not been (and will not be) submitted or published elsewhere while acceptance by the Bina Journal of Ophthalmology is under consideration. As the submitted materials including the manuscripts and figures cannot be returned, the authors are advised to retain copies of submitted materials and correspondence. All records will be wiped out 2 years after publication or rejection of the work.
The editorial board of the journal reserves the right to refuse any manuscript for publication as well as to edit any accepted manuscript based on the format of the journal. Publication of a paper does not mean that the editorial board agrees with its content and the authors must accept full responsibility for their work.
Manuscripts can be submitted via e-mail (email@example.com) or manually on CD or as hard copy (delivered to the journal office at the following address: Bina Journal of Ophthalmology, Eye Bank of the I.R. Iran, # 27, Yazdanpanah St., Africa Blvd., Tehran, Iran; Post code: 1968876711).
- Only papers written in Farsi are accepted.
- Manuscripts should be submitted as a single MS word document including the following sections with the beginning of each section on a new page in the following order: title page, abstract, text, appendices such as acknowledgments if any, references, tables, figures and legends.
- The manuscript should be typed in 1.5 line spacing, with margins of 2.5 cm on each side.
- Text should be Nazanin (for Farsi text), font size 14 and Times New Roman (for English text), font size 12.
- Full length of main text must not exceed ten 18-line pages.
- The manuscript should be paginated starting from the abstract.
- Figures should be submitted in digital format using JPEG or TIFF format.
- The authors’ names or affiliations should not appear anywhere on the manuscript pages or the images to ensure that peer-review is masked.
- A cover letter, signed by all authors with the telephone and fax numbers as well as e-mail address of the corresponding author must be provided. The author must warrant that the article is original, not under consideration for publication elsewhere and has not been published previously. The type of paper being submitted should also be stated.
- Corresponding authors are responsible for obtaining the approval of all co-authors regarding any subsequent revisions to a paper.
- Manuscripts should not exceed 3000 words in original articles and 1000 words in case reports.
The title page should provide the following information in both Farsi and English: (1) full names of the authors including first name, middle initial (if any) and last name along with highest academic degrees and affiliations; (2) the name of the corresponding author together with complete postal address, affiliation, telephone and fax numbers, and e-mail address; (3) the institute where the work was undertaken; (4) footnotes stating a conference or meeting where any part of the paper was presented; (5) footnotes stating any source of funding or financial interest where relevant; and (6) a running title of no more than 40 characters (not counting spaces).
- The abstract should be typed in both Farsi and English each on a separate page. It should be an accurate and concise synopsis of the paper and should not exceed 250 in original article and 150 words in case reports.
- No references should be quoted.
- Abstracts for original articles should be divided into five paragraphs with the following headings; Purpose, Methods, Results, Conclusion, and key words.
- Abstract for case reports should be structured as: Purpose, Case Report, and Conclusion.
- Abstract for review articles should be unstructured summarizing the content of the paper.
- No abstract is needed for other submissions.
- Three to five key words according to Mesh Database of Pub Med should also be written for each abstract.
- Avoid repetition between sections.
- Abbreviations and acronyms may be used where appropriate, but must always be defined where first used.
- The names and locations (city, country) of manufacturers of all equipment and non-generic drugs must be given.
- Avoid the use of footnotes.
- Main text for original articles should include Introduction, Methods, Results, and Discussion sections.
- Main text for case reports should include Introduction, Case Presentation, and Discussion sections.
- Main text for review articles generally includes Introduction and Conclusion along with other specific headings relevant to the paper content.
- Introduction should briefly describe the background information and references that inform the reader as to why the study was undertaken. An extensive literature is not necessary. The final paragraph of this section should clearly state the hypothesis or purpose of your study.
- In the method section, the aim and design of the study should be clearly described incorporating the number of subjects used to accomplish the aim. This section also includes the method used to assess the data and to control bias, along with the statistical analyses performed. For human studies, it is essential to state in the first paragraph whether or not ethical clearance and informed patient consent were obtained. The number and details of inclusion and exclusion criteria for recruiting subjects must be clearly stated. In randomized studies, details of the randomization procedure should be included. Give reference to established methods and describe new or substantially modified methods.
- Results should be presented in a clear logical sequence. Any exclusions or losses to follow-up that might affect the study population are required to be stated. Summarize only important observations and state the statistical significance of your findings.
- In the discussion, emphasize the advances in knowledge provided by your study and the conclusions that stem from them. The implications of the findings as well as their limitations should be discussed.
- References should be written in numerical order corresponding to the order in which they appear in the text.
- It is the responsibility of authors to determine the accuracy of the references.
- References should follow the Vancouver format.
- In the text, references are cited with superscript numerals separated by commas; three or more consecutive references are given as ranges.
- Papers in press may be included in the list of references.
- Abstracts and/or papers presented at meetings not in the public domain should not be cited. Neither should uncompleted work or work that has not been accepted for publication be included.
- The use of private communications should be given only in the text with the author and year provided in brackets. No number needs to be assigned to such references.
- Where there are 6 or fewer authors, all should be listed but for papers with more than 6 authors, cite the names of the first 6, followed by et al.
- References should note more than 30 in original articles and 10 in case reports.
Examples of references
- Journal article. Include author names and initials, paper title, abbreviated journal title, year of publication, volume number, and first and last page numbers of paper.
Ursell PG, Spatton DJ, Pande MV, Hollick E, Borman S, Boyce J, et al. Relationship between intraocular lens biomaterials and posterior capsule opacification. J Cataract Refract Surg 1998;24:352-360.
- Complete book. Include authors; editors’ names, title of the book, edition, city/country of publication, publisher name and year of publication.
Bradley WJ, Neurology in clinical practice. 4th ed. Philadelphia: Butterworth-Heinemann; 2004.
- Chapter in book. Include authors of the relevant chapter, chapter title followed by “In:” and editors’ names, title of book, edition, town/country of publication and publisher name, year of publication, and first and last page numbers of the chapter.
Thompson J. Proliferative vitreoretinopathy. In: Ryan SJ (ed). Retina. 3rd ed. St. Louis: Mosby; 2001: 1309-1349.
- Conference proceedings. Include names of editors, title of publication, title of meeting, date and location of meeting, town/country of publication and publisher name, and year of publication.
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.
- Conference paper. Include author(s) and title of paper followed by "In:" and the details of the Conference Proceedings in which it appears.
Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.
- Internet. Include author(s), title of article, URL and accessed date.
Keller M, Hughes KF, Pethig R. Evidence based radiology [Web Page]. Available at
http://www.evidencebasedradiology.net/ebr_practice/ebr_practice.html (Accessed 14 July 2004).
Tables and Figures
- All tables and figures should be referred to specifically and numbered consecutively in the order in which they appear in the text.
- Tables should be self-explanatory with no duplication of data. All abbreviations in tables should be defined in footnotes.
- Repetition of material from the text should be avoided and any abbreviations used should be clearly defined in the caption.
- Patient identification must be obscured in the figures.
- For histopathological images, the type of staining and magnification should be noted.
- In original articles tables and figures should not be exceeded more than 10.
- Authors must declare any source of funding and potential conflict of interest at the end of the article.
- Authors should knowledge organization providing the source of funding.
- Type of contribution of each author should be mentioned in the end of the manuscript.
- It is necessary to mention the code of registration in www.IRCT.ir in clinical trials.
Peer review process
- All submitted manuscripts will undergo peer-review by at least 2 experts in the field who will receive manuscripts with blind title pages. The corresponding author is notified as soon as possible of the editor's decision to accept or reject the manuscript, or whether it requires modifications.
- When revisions are requested, all points raised by the reviewers must be answered by the authors on a separate sheet, and returned with the revised manuscript. In the event of any disagreement with any specific comments, authors are free to explain their reasoning when resubmitting their paper.
- Each accepted paper is edited so that its message is clear and conforms to the style of the journal. Before publication, authors receive page proofs for final revision.